Xi Chen

机构：Hong Kong Polytechnic University, The University of Queensland, Nankai University, Fourth People's Hospital of Sichuan Province, Institute of Organic Chemistry, Anhui Provincial Center for Disease Control and Prevention, Jilin Province Science and Technology Department, Agilent Technologies (Australia), Jilin Agricultural University, Zigong First People's Hospital, Capital University of Physical Education and Sports, Luoyang Orthopedic-Traumatological Hospital of Henan Province, East China Normal University · ORCID：0000-0002-3160-614X

发表论文 933 篇 · 总被引 26007 次 · h-index 81

代表论文

• Sacituzumab tirumotecan in participants with advanced or metastatic urothelial carcinoma and disease progression after chemotherapy and immune checkpoint inhibitors (2025 · Annals of Oncology · 被引 5)
• l -Fucose is a candidate monosaccharide neuromodulator and mitigates Alzheimer’s synaptic deficits (2025 · Science Advances · 被引 3)
• Optimization of pyrrole-2-carboxamide to develop a potent antituberculosis agent with improved physicochemical property and druggability (2025 · Bioorganic Chemistry · 被引 3)
• Feasibility of Rapid Regulatory Differentiation of TNF Receptor 2-Fc Fusion Protein Products from Various Manufacturers in the Chinese Market Using a Novel Mass Spectrometry-Based Multi-attribute Method (MAM) (2025 · Journal of the American Society for Mass Spectrometry · 被引 3)
• iRGD-engineered exosomes mediate siMYC delivery for effective tumor suppression in triple-negative breast cancer (2025 · Nanoscale · 被引 2)
• Cooperative Bond Activation and Catalysis by Tetrylene-Stabilized Low-Valent Main-Group Compounds (2026 · Accounts of Chemical Research · 被引 1)